Wave Life Sciences Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GSK PLC | 02/12/2026 | 18.25 M | $310.18 M | 100.00% | 10.88% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 18.20 M | $309.45 M | 0.01% | 10.85% |
| FMR LLC | 02/17/2026 | 15.14 M | $257.31 M | 195.03% | 9.02% |
| BLACKROCK, INC. | 02/12/2026 | 12.65 M | $215.03 M | 21.26% | 7.54% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 9.79 M | $166.36 M | -32.82% | 5.83% |
| MAVERICK CAPITAL LTD | 02/13/2026 | 9.28 M | $157.76 M | 10.59% | 5.53% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 7.41 M | $125.93 M | 83.15% | 4.42% |
| DARWIN GLOBAL MANAGEMENT, LTD. | 02/17/2026 | 7.30 M | $125.17 M | 100.00% | 4.35% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 6.58 M | $111.88 M | 4.49% | 3.92% |
| M28 CAPITAL MANAGEMENT LP | 02/13/2026 | 5.66 M | $96.30 M | 0.00% | 3.38% |
| FEDERATED HERMES, INC. | 02/12/2026 | 4.74 M | $80.66 M | 26.50% | 2.83% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/11/2026 | 4.10 M | $69.62 M | 115.69% | 2.44% |
| 683 CAPITAL MANAGEMENT, LLC | 02/17/2026 | 4.02 M | $68.26 M | -3.25% | 2.39% |
| VANGUARD GROUP INC | 01/29/2026 | 3.57 M | $60.75 M | 13.82% | 2.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.17 M | $53.90 M | 8.63% | 1.89% |
| STATE STREET CORP | 02/13/2026 | 3.00 M | $50.93 M | 5.26% | 1.79% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 2.85 M | $48.52 M | 34.30% | 1.70% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 2.70 M | $45.90 M | 28.57% | 1.61% |
| EMERALD ADVISERS, LLC | 02/09/2026 | 2.46 M | $41.74 M | -18.08% | 1.46% |
| SIREN, L.L.C. | 02/13/2026 | 2.45 M | $41.65 M | -33.72% | 1.46% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 2.17 M | $36.87 M | -52.43% | 1.29% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 2.04 M | $34.68 M | -29.78% | 1.22% |
| PFIZER INC | 02/12/2026 | 1.88 M | $31.88 M | 0.00% | 1.12% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/17/2026 | 1.85 M | $31.52 M | 100.00% | 1.11% |
| BELLEVUE GROUP AG | 02/17/2026 | 1.49 M | $25.34 M | -63.60% | 0.89% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 02/09/2026 | 1.41 M | $24.05 M | -19.90% | 0.84% |
| RTW INVESTMENTS, LP | 02/17/2026 | 1.35 M | $22.95 M | 50.00% | 0.80% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.19 M | $20.25 M | 19.33% | 0.71% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.03 M | $17.56 M | 2.11% | 0.62% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 1.01 M | $17.25 M | 81.08% | 0.60% |
| JPMORGAN CHASE & CO | 02/11/2026 | 892.89 K | $15.18 M | 3.81% | 0.53% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 883.59 K | $15.02 M | 222.96% | 0.53% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 805.90 K | $13.83 M | 5,024.64% | 0.48% |
| CITADEL ADVISORS LLC | 02/17/2026 | 792.30 K | $13.47 M | 1,048.26% | 0.47% |
| CITADEL ADVISORS LLC | 02/17/2026 | 789.96 K | $13.43 M | 100.00% | 0.47% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 785.70 K | $13.36 M | 613.62% | 0.47% |
| CITADEL ADVISORS LLC | 02/17/2026 | 772.70 K | $13.14 M | 603.73% | 0.46% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 749.45 K | $12.74 M | 33.12% | 0.45% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 722.24 K | $12.28 M | 100.00% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 634.10 K | $10.78 M | 4,494.93% | 0.38% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 600.00 K | $10.20 M | 100.00% | 0.36% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 584.63 K | $9.94 M | 49.62% | 0.35% |
| JANE STREET GROUP, LLC | 02/12/2026 | 574.40 K | $9.76 M | 15.57% | 0.34% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 500.00 K | $8.50 M | 100.00% | 0.30% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2026 | 492.44 K | $8.37 M | -8.88% | 0.29% |
| 02/17/2026 | 447.85 K | $7.61 M | 100.00% | 0.27% | |
| EXOME ASSET MANAGEMENT LLC | 02/13/2026 | 421.49 K | $7.17 M | 100.00% | 0.25% |
| UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 01/28/2026 | 411.49 K | $7.00 M | 11.61% | 0.25% |
| MORGAN STANLEY | 02/13/2026 | 409.66 K | $6.96 M | -19.24% | 0.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 408.17 K | $6.94 M | 716.33% | 0.24% |
Wave Life Sciences Ltd. institutional Ownership - FAQ's
During the previous two years, 293 institutional investors and hedge funds held shares of Wave Life Sciences Ltd.. The most heavily invested institutionals were:
EMERALD ADVISERS, LLC: 1.26 M
Pictet Asset Management Holding SA: 1.15 M
EMERALD MUTUAL FUND ADVISERS TRUST: 814,529
Nuveen, LLC: 657,720
abrdn plc: 550,000
UBS Group AG: 538,997
108.95% of Wave Life Sciences Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 290.04 M shares in the last 24 months. This purchase volume represents approximately $3.85 B in transactions.